Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melphalan may be a more potent leukemogen than cyclophosphamide.
Greene MH, Harris EL, Gershenson DM, Malkasian GD Jr, Melton LJ 3rd, Dembo AJ, Bennett JM, Moloney WC, Boice JD Jr. Greene MH, et al. Among authors: gershenson dm. Ann Intern Med. 1986 Sep;105(3):360-7. doi: 10.7326/0003-4819-105-3-360. Ann Intern Med. 1986. PMID: 3740675 Clinical Trial.
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, Broxmeyer HE, Kudelkà AP, Freedman RS, Edwards CL, Gershenson D, Jones D, Ashby M, Kavanagh JJ. Vadhan-Raj S, et al. Ann Intern Med. 2000 Mar 7;132(5):364-8. doi: 10.7326/0003-4819-132-5-200003070-00005. Ann Intern Med. 2000. PMID: 10691586 Clinical Trial.
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Donato ML, Gershenson DM, Wharton JT, Ippoliti CM, Aleman AS, Bodurka-Bevers D, Bevers MW, Burke TW, Levenback CF, Wolf JK, Freedman RS, Bast RC Jr, Gajewski JL, Champlin RE. Donato ML, et al. Among authors: gershenson dm. Gynecol Oncol. 2001 Sep;82(3):420-6. doi: 10.1006/gyno.2001.6326. Gynecol Oncol. 2001. PMID: 11520135 Clinical Trial.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA, Farley JH. Oliver KE, et al. Among authors: gershenson dm. Gynecol Oncol. 2017 Nov;147(2):243-249. doi: 10.1016/j.ygyno.2017.08.004. Epub 2017 Aug 12. Gynecol Oncol. 2017. PMID: 28807367 Free PMC article.
495 results